☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Spero Therapeutics
Spero Therapeutics Reports the US FDA’s IND Clearance of SPR206 for the Treatment of MDR Gram-Negative Bacterial Infections
February 29, 2024
PharmaShots Weekly Snapshots (July 05 - 09, 2021)
July 9, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
